» Articles » PMID: 28676858

Jacalin Has Chemopreventive Effects on Colon Cancer Development

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2017 Jul 6
PMID 28676858
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer, which is one of the most common causes of cancer-related deaths worldwide, has a slow natural history that provides a great opportunity for prevention strategies. Plant-derived natural products have received considerable attention because of their inherent colorectal cancer chemopreventive effects. The plant lectin jacalin specifically recognizes the tumor-associated Thomsen-Friedenreich antigen and has antiproliferative effects on human colon cancer cells, highlighting its potential antitumor activity. To evaluate jacalin's potential application in colorectal cancer chemoprevention, we studied its effects on the early stages of carcinogenesis. Balb/c mice were given 4 intrarectal deposits of 0.1 ml solution of Methyl-N'-Nitro-N-Nitroso-Guanidine (5 mg/ml) twice a week (with a 3-day interval) for 2 weeks. Starting 2 weeks before carcinogen administration, animals were treated orally with jacalin (0.5 and 25 g) three times a week (on alternate weekdays) for 10 weeks. We show that jacalin treatment reduced the number of preneoplastic lesions in carcinogen-exposed mice. This anticarcinogenic activity was associated with decreased colonic epithelial cell proliferation and stromal COX-2 expression and with increased intestinal production of TNF-. Our results demonstrate that jacalin is able to modulate the early stages of colon carcinogenesis and emphasize its promising chemopreventive activity in colorectal cancer.

Citing Articles

Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line.

Petrova L, Gergov N, Stoup M, Zapryanova S, Van Damme E, Lebegue N Int J Mol Sci. 2023; 24(24).

PMID: 38139227 PMC: 10743388. DOI: 10.3390/ijms242417399.


Changes in Gastric Mucosal Glycosylation Before and After Helicobacter pylori Eradication Using Lectin Microarray Analysis.

Ogawa R, Okimoto T, Kodama M, Togo K, Fukuda K, Okamoto K Turk J Gastroenterol. 2022; 33(2):88-94.

PMID: 35238778 PMC: 9128452. DOI: 10.5152/tjg.2021.201116.


ArtinM Grafted Phospholipid Nanoparticles for Enhancing Antibiotic Cellular Uptake Against Intracellular Infection.

Suciati T, Nafisa S, Nareswari T, Juniatik M, Julianti E, Wibowo M Int J Nanomedicine. 2020; 15:8829-8843.

PMID: 33304099 PMC: 7724644. DOI: 10.2147/IJN.S275449.

References
1.
Smith W, Dewitt D, Garavito R . Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000; 69:145-82. DOI: 10.1146/annurev.biochem.69.1.145. View

2.
Tanaka T . Colorectal carcinogenesis: Review of human and experimental animal studies. J Carcinog. 2009; 8:5. PMC: 2678864. DOI: 10.4103/1477-3163.49014. View

3.
Brasky T, Liu J, White E, Peters U, Potter J, Walter R . Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative. Int J Cancer. 2014; 135(8):1869-83. PMC: 5592086. DOI: 10.1002/ijc.28823. View

4.
Xin B, Yokoyama Y, Shigeto T, Mizunuma H . Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers. Pathol Oncol Res. 2007; 13(4):365-9. DOI: 10.1007/BF02940318. View

5.
Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K . Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol. 2006; 12(9):1336-45. PMC: 4124307. DOI: 10.3748/wjg.v12.i9.1336. View